drugset / Trial / NCT02978391

UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD

NCT02978391 ↗

Completed 76 enrolled Next Biomedical Co., Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

UI-EWD (NextBiomedical Co, Incheon, South Korea), a new hemostatic powder for endoscopic treatment of high-risk bleeding peptic ulcers and bleeding after ESD/EMR.

Timeline

Start
2016-05-23
Primary completion
2016-11-30
Completion
2017-09-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Epinephrine Other / unclassified — Other